Evotec acquires Cell Culture Service GmbH

08-Jan-2013 - Germany

Evotec announced the acquisition of all shares in Cell Culture Service GmbH (CCS), a Hamburg-based company which supports the cell culture needs of a customer base of biotech and Pharmaceutical companies. CCS is supplier of custom cells and cell-based reagents such as recombinant assay cell lines, assay-ready Frozen Instant Cells, membranes, and proteins for high throughput screening.

'Through the acquisition of CCS, Evotec strengthens its cell culture capabilities and gains access to a growing base of customers using cell-based assays in their drug discovery processes. CCS' experience and technologies for large scale cell production are a perfect fit with Evotec's screening and in vitro pharmacology activities', said Dr Mario Polywka, Chief Operating Officer of Evotec AG.

Other news from the department business & finance

More news from our other portals

So close that even
molecules turn red...